Usefulness of bone turnover markers as predictors of mortality risk, disease progression and skeletal-related events appearance in patients with prostate cancer with bone metastases following treatment with zoledronic acid: TUGAMO study
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
URI: http://hdl.handle.net/20.500.11940/904
PMID: 23722472
DOI: 10.1038/bjc.2013.270
ISSN: 0007-0920
Fecha de publicación
2013Título de revista
BRITISH JOURNAL OF CANCER
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)